Seeking Alpha

Medtronic (MDT) announces interim findings from clinical trials which show that biventricular...

Medtronic (MDT) announces interim findings from clinical trials which show that biventricular pacing may offer a significant advantage and improved patient outcomes over conventional right ventricular pacing among pacemaker patients. The findings were presented as a late-breaking clinical trial at the American Heart Association's 2012 Scientific Sessions, and show a 27% relative risk reduction in the composite of death and healthcare utilization visits among patients requiring intravenous heart failure therapy.
From other sites
Comments (1)
  • Duane Byron Carlson
    , contributor
    Comments (139) | Send Message
     
    Adding to my DRIP program. Any comments on Medtronic Dividend
    Reinvestment Program?
    8 Nov 2012, 01:45 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector